Michael Ferraro
@mcferraro.bsky.social
68 followers 100 following 8 posts
Doctoral candidate, NeuRA & UNSW Medicine
Posts Media Videos Starter Packs
Reposted by Michael Ferraro
Reposted by Michael Ferraro
Is medical practice ahead of the evidence?
Out today 🚨 Our Cochrane review of 67 RCTs finds no clear evidence of benefit for ketamine or other NMDA antagonists for chronic pain. IV ketamine associated with risk of psychotomimetic effects, nausea, and vomiting. doi.org/10.1002/1465...
Ketamine and other NMDA receptor antagonists for chronic pain - Ferraro, MC - 2025 | Cochrane Library
Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.
doi.org
Out today 🚨 Our Cochrane review of 67 RCTs finds no clear evidence of benefit for ketamine or other NMDA antagonists for chronic pain. IV ketamine associated with risk of psychotomimetic effects, nausea, and vomiting. doi.org/10.1002/1465...
Ketamine and other NMDA receptor antagonists for chronic pain - Ferraro, MC - 2025 | Cochrane Library
Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.
doi.org
Reposted by Michael Ferraro
Despite a large body of new evidence, our best treatments for neuropathic pain continue to provide only modest benefits, write Michael Ferraro and Dr Nadia Soliman

buff.ly/F5irUsl
One-Page Patient Fact Sheets for Low Back Pain in Primary Care url:https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2836549?utm_source=bluesky&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=072425
Reposted by Michael Ferraro
Despite a large body of new evidence, our best treatments for neuropathic pain continue to provide only modest benefits, write Michael Ferraro and Dr Nadia Soliman

buff.ly/F5irUsl
Reposted by Michael Ferraro
Reposted by Michael Ferraro
RCT: Among patients with low back pain, a nondirective information sheet listing treatment options improved patient-reported preparedness for decision-making more than a directive advice sheet. https://ja.ma/4nUr96z
Reposted by Michael Ferraro
#PAIN joins with other editors of pain-related journals to affirm our editorial commitment to trust and integrity in science. Read our joint statement at bit.ly/4lj3b3b
Reposted by Michael Ferraro
Editorial: The editors-in-chief from @thejournalofpain.bsky.social & other pain/anesthesia journals come together to align and strengthen initiatives to enhance research integrity, trust, and impact across our field.

Full: doi.org/10.1016/j.jp...
Redirecting
doi.org
Reposted by Michael Ferraro
Reposted by Michael Ferraro
International #ResearchIntegrity conference taking place in beautiful Sydney Australia on 16-18 November 2025 🐨 🌏
Great speakers including @elisabethbik.bsky.social @jdwilko.bsky.social @jasonchin.bsky.social
For more info contact
@simongandevia.bsky.social 🧪
International Research Integrity Conference. I am arranging this in Sydney in November 16-18th 2025. researchintegrityconf.com Note the excellent speaker list. Contact me!
International Research Integrity Conference | 17-18 November 2025, Sydney, Australia
researchintegrityconf.com
Reposted by Michael Ferraro
International Research Integrity Conference. I am arranging this in Sydney in November 16-18th 2025. researchintegrityconf.com Note the excellent speaker list. Contact me!
International Research Integrity Conference | 17-18 November 2025, Sydney, Australia
researchintegrityconf.com
Updated @iasp.bsky.social NeuPSIG systematic review & guideline for treatment of neuropathic pain now published in @thelancetneuro.bsky.social. A privilege to contribute to this project, brilliantly led by @nadiasoliman.bsky.social

doi.org/10.1016/S147...
Redirecting
doi.org